Open AccessSignaling pathway of insulin-like growth factor-II as a target of molecular therapy for hepatoblastoma
Author(s) -
M. Tomizawa,
Hiromitsu Saisho
Publication year - 2006
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v12.i40.6531
Subject(s) - hepatoblastoma , wortmannin , insulin like growth factor , cell growth , growth factor , ly294002 , phosphoinositide 3 kinase , pi3k/akt/mtor pathway , biology , signal transduction , microbiology and biotechnology , cancer research , chemistry , endocrinology , medicine , receptor , biochemistry
To address the possibility that insulin-like growth factor (IGF)-II is a growth factor and its signaling pathway so as to develop a molecular therapy for hepatoblastoma.